[Adverse effects of the tyrosine-kinase inhibitor sunitinib, a new drug for the treatment of advanced renal-cell cancer]. [electronic resource]
Producer: 20070709Description: 1142-7 p. digitalISSN:- 0028-2162
- Aged
- Antineoplastic Agents -- adverse effects
- Carcinoma, Renal Cell -- drug therapy
- Fatal Outcome
- Female
- Humans
- Indoles -- adverse effects
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- adverse effects
- Safety
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.